Clinical Trial Update: Construction of a Prognostic and Prediction Model for Perioperative Immunotherapy in NSCLC: A Multi - Omics Perspective

View source ↗

Summary

This trial aims to construct a multi-omics prognostic and predictive model to guide perioperative immunotherapy in non-small cell lung cancer (stages II and III…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Ziming Li | Conditions: NSCLC Stage IIIA/B, NSCLC Stage II | Status: NOT_YET_RECRUITING